Philadelphia Institutions Launch Glaucoma Research Retreat - Takeaway - MDSpire
Conference News

Philadelphia Institutions Launch Glaucoma Research Retreat

Researchers from 5 institutions met to discuss neuroprotection, diagnostics, gene therapy, and regional collaboration.

  • May 1, 2026

  • 3 min

Share

  • 1

    Focus on glaucoma science and neuroprotection.

  • 2

    Collaboration among Wills Eye, Scheie Eye Institute, and more.

  • 3

    Keynote by Adriana Di Polo on neurodegeneration.

  • 4

    Importance of imaging biomarkers in tracking disease.

  • 5

    Team science models enhance research synergy.

  • 6

    New treatment strategies beyond lowering intraocular pressure.

  • 7

    Future progress depends on coordinated networks.

Original Source(s)

Philadelphia Institutions Launch Glaucoma Research Retreat

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.